Browse studies, page 425
Page 425 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- A comparison between dexlansoprazole modified release-based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial Infection and drug resistance, 2019
- East Asian perspective on the interaction between proton pump inhibitors and clopidogrel Journal of gastroenterology and hepatology, 2017
- Investigation of the interaction between proton pump inhibitors and clopidogrel using VerifyNow P2Y12 assay Medicine, 2020
- Pharmacokinetics and pharmacodynamics of the proton pump inhibitors Journal of neurogastroenterology and motility, 2013
- Lack of electrocardiographic effect of dexlansoprazole MR, a novel modified-release formulation of the proton pump inhibitor dexlansoprazole, in healthy participants Journal of clinical pharmacology, 2009
- Use of proton pump inhibitors in the management of gastroesophageal varices: a systematic review The Annals of pharmacotherapy, 2015
- Insights into the future of gastric acid suppression Nature reviews. Gastroenterology & hepatology, 2009
- Proton Pump Inhibitors and the Risk of Dementia The Journal of clinical psychiatry, 2026
- Identification of novel signal of proton pump inhibitor-associated drug reaction with eosinophilia and systemic symptoms: a disproportionality analysis International journal of clinical pharmacy, 2024
- In Defense of Secondary Pharmaceutical Patents in Drug Discovery and Development ACS medicinal chemistry letters, 2020
- Phase 4 Study in Patients From Asia With Gastroesophageal Reflux Disease Treated With Dexlansoprazole Journal of neurogastroenterology and motility, 2020
- Dexlansoprazole, a modified release formulation of an enantiomer of lansoprazole, for the treatment of reflux esophagitis Current opinion in investigational drugs (London, England : 2000), 2008
- Bioavailability of a dexlansoprazole delayed-release orally disintegrating tablet: effects of food and mode of administration Clinical and experimental gastroenterology, 2017
- Proton pump inhibitors for the treatment of patients with erosive esophagitis and gastroesophageal reflux disease: current evidence and safety of dexlansoprazole Clinical and experimental gastroenterology, 2016
- Review article: dual delayed release formulation of dexlansoprazole MR, a novel approach to overcome the limitations of conventional single release proton pump inhibitor therapy Alimentary pharmacology & therapeutics, 2009
- Pharmacokinetics and safety of dexlansoprazole MR in adolescents with symptomatic GERD. Journal of pediatric gastroenterology and nutrition, 2012
- Dexlansoprazole is Effective in Relieving Heartburn during the Fasting Month of Ramadan Digestive diseases (Basel, Switzerland), 2019
- Efficacy of dexlansoprazole-based triple therapy for Helicobacter pylori infections Therapeutic advances in gastroenterology, 2019
- Dexlansoprazole for the treatment of esophagitis and GERD. Drugs of today (Barcelona, Spain : 1998), 2010
- Delayed release dexlansoprazole in the treatment of GERD and erosive esophagitis Clinical and experimental gastroenterology, 2009
- Analysis of infection-related adverse events induced by proton pump inhibitors based on the FAERS and JADER databases Medicine, 2025
- Pharmacokinetics and safety of dexlansoprazole MR in pediatric patients with symptomatic gastroesophageal reflux disease Clinical and experimental gastroenterology, 2014
- Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital Clinical and translational science, 2021
- Determination of S-(-)-lansoprazole in dexlansoprazole preparation by capillary zone electrophoresis Archives of pharmacal research, 2017
- Potent Acid Suppression with PPIs and P-CABs: What's New? Current treatment options in gastroenterology, 2018
- Pharmacokinetic/Pharmacodynamic Evaluation of Dexlansoprazole Infusion Injection Compared with Lansoprazole in Healthy Chinese Adults Clinical drug investigation, 2019
- Historical perspective of gastroesophageal reflux disease clinical treatment. Arquivos de gastroenterologia, 2019
- Comparison of acid-lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta-Analysis Neurogastroenterology and motility, 2023
- Enantioselective disposition of lansoprazole and rabeprazole in human plasma Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2006
- Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific Region Journal of neurogastroenterology and motility, 2016
- Dexlansoprazole and Esomeprazole Do Not Affect Bone Homeostasis in Healthy Postmenopausal Women Gastroenterology, 2019
- PPI Long Term Use: Risk of Neurological Adverse Events? Frontiers in neurology, 2018
- Fragments of e-Cadherin as Biomarkers of Non-erosive Reflux Disease Digestive diseases and sciences, 2018
- Safety, tolerability, pharmacokinetics and pharmacodynamics of dexlansoprazole injection in healthy Chinese subjects European journal of clinical pharmacology, 2017
- Bioavailability, safety, and pharmacodynamics of delayed-release dexlansoprazole administered as two 30 mg orally disintegrating tablets or one 60 mg capsule Therapeutic advances in gastroenterology, 2016
- Potassium-Competitive Acid Blockers (P-CABs): Are They Finally Ready for Prime Time in Acid-Related Disease? Clinical and translational gastroenterology, 2015
- Determination of Proton Pump Inhibitors by Spectrophotometric, Chromatographic and by Hyphenated Techniques: A Review Critical reviews in analytical chemistry, 2021
- Deciphering the nature of binding of dexlansoprazole with DNA: Biophysical and docking approaches International journal of biological macromolecules, 2022
- Acceptance of recommendations by a pharmacogenetics clinic Pharmacogenomics, 2026
- Comparative Efficacy of Dexlansoprazole, Pantoprazole, Esomeprazole, and Rabeprazole in Achieving Optimal 24-Hour Intragastric pH Control: A Randomized Crossover Study Using Ambulatory pH Monitoring Cureus, 2024
- Pharmacokinetics and pharmacodynamics of a known active PPI with a novel Dual Delayed Release technology, dexlansoprazole MR: a combined analysis of randomized controlled clinical trials Current medical research and opinion, 2009
- Effects of genetic polymorphisms on the pharmacokinetics and pharmacodynamics of proton pump inhibitors Pharmacological research, 2020
- Treatment of gastroesophageal reflux disease: two new oral formulations dexlansoprazole MR and esomezol (esomeprazole strontium) Expert opinion on pharmacotherapy, 2014
- A Pilot Randomized Controlled Study of Dexlansoprazole MR-Based Triple Therapy for Helicobacter Pylori Infection Medicine, 2016
- Managing gastroesophageal reflux disease - comparative efficacy and outcomes of dexlansoprazole MR. Therapeutics and clinical risk management, 2015
- Dexlansoprazole MR for the management of gastroesophageal reflux disease Expert review of gastroenterology & hepatology, 2011
- Perils and pitfalls of long-term effects of proton pump inhibitors Expert review of clinical pharmacology, 2013
- Comparison of Pharmacodynamics between Tegoprazan and Dexlansoprazole Regarding Nocturnal Acid Breakthrough: A Randomized Crossover Study Gut and liver, 2023
- Absorption, distribution, metabolism and excretion of [14C]dexlansoprazole in healthy male subjects Clinical drug investigation, 2012
- Dexlansoprazole: A proton pump inhibitor with a dual delayed-release system Clinical therapeutics, 2010
- Dexlansoprazole - a new-generation proton pump inhibitor Przeglad gastroenterologiczny, 2015
- Association Between Proton Pump Inhibitors and Microscopic Colitis The Annals of pharmacotherapy, 2017
- Dexlansoprazole modified release: in erosive oesophagitis and non-erosive reflux disease Drugs, 2010
- Proton Pump Inhibitors: Risk for Myopathy? The Annals of pharmacotherapy, 2017
- Dexlansoprazole acts as a disruptor of the aryl hydrocarbon receptor and ITE. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2025
- Dexlansoprazole prevents pulmonary artery hypertension by inhibiting pulmonary artery smooth muscle cell to fibroblast transition American journal of translational research, 2022
- Suppression of vacuolar-type ATPase and induction of endoplasmic reticulum stress by proton pump inhibitors Journal of the Chinese Medical Association : JCMA, 2022
- Development of Dexlansoprazole Delayed-Release Capsules, a Dual Delayed-Release Proton Pump Inhibitor Journal of pharmaceutical sciences, 2019
- Dexlansoprazole MR: a review Annals of medicine, 2011
- The Effect of Dexlansoprazole on Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis International journal of molecular sciences, 2024
- Pharmacokinetics and pharmacodynamics of an orally disintegrating tablet formulation of dexlansoprazole Therapeutic advances in gastroenterology, 2016
- Dexlansoprazole in the treatment of esophagitis and gastroesophageal reflux disease The Annals of pharmacotherapy, 2010
- Gateways to clinical trials Methods and findings in experimental and clinical pharmacology, 2007
- Acid-suppressive drugs: A systematic review and network meta-analysis of their nocturnal acid-inhibitory effect Pharmacotherapy, 2024
- (R)-(+)-2-{[(3-Methyl-4-nitro-pyridin-2-yl)meth-yl]sulfin-yl}-1H-benzimidazole Acta crystallographica. Section E, Structure reports online, 2011
- Comparative Efficacy of P-CAB vs Proton Pump Inhibitors for Grade C/D Esophagitis: A Systematic Review and Network Meta-analysis The American journal of gastroenterology, 2024
- Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding The Cochrane database of systematic reviews, 2022
- Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update Drug safety, 2014
- An update on drug-drug interactions associated with proton pump inhibitors Expert opinion on drug metabolism & toxicology, 2022
- Proton Pump Inhibitors and Bone Health: An Update Narrative Review International journal of molecular sciences, 2022
- An Integrative Eight-Dimensional Nonlinear Dynamical Model for Polycystic Ovary Syndrome Management: First-Principles Derivation, Global Asymptotic Stability Analysis, Optimal Control, Bayesian Inference, Sensitivity Analysis, and Translational Framework Zenodo (CERN European Organization for Nuclear Research), 2026
- Family-based quantitative trait meta-analysis implicates rare noncoding variants in DENND1A in pathogenesis of polycystic ovary syndrome bioRxiv (Cold Spring Harbor Laboratory), 2018
- Transcriptomic analysis identifies four novel receptors potentially linking endometrial cancer with polycystic ovary syndrome and generates a transcriptomic atlas Oncotarget, 2023
- Discovering therapeutic possibilities for polycystic ovary syndrome by targeting XIST and its associated ceRNA network through the analysis of transcriptome data Scientific Reports, 2024
- Bioactive Compounds from Allium Species: Chemical Features and Molecular Mechanisms in Polycystic Ovary Syndrome—A Narrative Review Compounds, 2026
- Exploring the Combination of Traditional Chinese and Allopathic Medicine in the Treatment of Polycystic Ovary Syndrome from the Perspective of Modern Medicine Drug Design Development and Therapy, 2025
- Herbal therapeutics in pathogenic conditions affecting women: A focused review on polycystic ovary syndrome and sexually transmitted infection’s Journal of Pharmacognosy and Phytochemistry, 2026
- Global research trends and knowledge mapping of nutritional supplements in polycystic ovary syndrome: a bibliometric study (2006–2024) Middle East Fertility Society Journal, 2025
- Exploring the mechanisms of Cangfu Daotan decoction in homotherapy for heteropathy of polycystic ovary syndrome, insulin resistance, infertility, and obesity Medicine, 2026
- Integrated Network Pharmacology and Clinical Study to Reveal the Effects and Mechanisms of Bushen Huoxue Huatan Decoction on Polycystic Ovary Syndrome Evidence-based Complementary and Alternative Medicine, 2022
- Pharmacological effects of Chinese herbal active compounds in the intervention of polycystic ovary syndrome: focusing on molecular mechanisms All Life, 2026
- Therapeutic potential of epigallocatechin gallate in gynecologic cancer, endometriosis, polycystic ovary syndrome: a mechanistic and translational perspective Frontiers in Nutrition, 2026
- Statins for polycystic ovary syndrome in varying resource settings: a phenome-wide association study and evidence synthesis Frontiers in Pharmacology, 2025
- miR‑28‑5p suppresses cell proliferation and weakens the progression of polycystic ovary syndrome by targeting prokineticin‑1 Molecular Medicine Reports, 2019
- Protein Expression and Bioinformatics Study of Granulosa Cells of Polycystic Ovary Syndrome Expressed Under the Influence of DHEA Clinical Medicine Insights Endocrinology and Diabetes, 2023
- Polycystic Ovary Syndrome (PCOS) Inhibitory Drug Screening from Selective Inositols Toxicology and Applied Pharmacology Insights, 2023
- Metabolic identification of bioactive compounds of Citrus reticulata cultivars extracts for a novel approach to polycystic ovary syndrome Scientific Reports, 2025
- Herbal Remedies for Polycystic Ovary Syndrome: A Concise Review from the Perspective of Traditional Iranian Medicine Journal of Biochemicals and Phytomedicine, 2026
- Identification of polycystic ovary syndrome potential drug targets based on pathobiological similarity in the protein-protein interaction network Oncotarget, 2016
- Effect of Wenshentiaojing Decoction on Hormone Level and Follicular Number in Patients with Menstrual Disorder of Polycystic Ovary Syndrome Evidence-based Complementary and Alternative Medicine, 2021
- Edible bird’s nest ameliorates hyperandrogenism and gonadotropin imbalance in a rat model of polycystic ovary syndrome Frontiers in Nutrition, 2026
- The Efficacy of Chinese Herbal Medicine in Animal Models of Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis Evidence-based Complementary and Alternative Medicine, 2022
- Investigation of the Mechanism of Zishen Yutai Pills on Polycystic Ovary Syndrome: A Network Pharmacology and Molecular Docking Approach Evidence-based Complementary and Alternative Medicine, 2021
- Exploring the role of the NLRP3 Inflammasome in polycystic ovary syndrome: therapeutic potential of herbal medicines Journal of Ovarian Research, 2026
- Exploiting molecular genetic diagnoses of polycystic ovary syndrome to achieve better patient outcome Murdoch University Research Portal, 2018
- Role of Functional Foods and Nutraceutical Compounds in Alleviating Polycystic Ovary Syndrome: A Narrative Review Cureus, 2026
- Integrative Approaches to Ovulation Induction in Polycystic Ovary Syndrome: A Narrative Review of Conventional and Complementary Therapies Biomedicines, 2025
- An Analysis of the Clinical Medication Rules of Traditional Chinese Medicine for Polycystic Ovary Syndrome Based on Data Mining Evidence-based Complementary and Alternative Medicine, 2023
- Exome‐based genome‐wide screening of rare variants associated with the risk of polycystic ovary syndrome Reproductive Medicine and Biology, 2023
- The role of RAD51 regulators and variants in primary ovarian insufficiency, endometriosis, and polycystic ovary syndrome NAR Molecular Medicine, 2024
